Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.

Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.

Inclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we...

Full description

Bibliographic Details
Main Authors:	Paula Castellanos Otero, Tiffany W Todd, Wei Shao, Caroline J Jones, Kexin Huang, Lillian M Daughrity, Mei Yue, Udit Sheth, Tania F Gendron, Mercedes Prudencio, Björn Oskarsson, Dennis W Dickson, Leonard Petrucelli, Yong-Jie Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298080&type=printable

Similar Items

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
by: Simon D'Alton, et al.
Published: (2014-01-01)

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases
by: Anna Calliari, et al.
Published: (2024-03-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
by: Keith A. Josephs, et al.
Published: (2019-07-01)

Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
by: Keith Anthony Josephs, et al.
Published: (2023-12-01)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
by: Jeannie Chew, et al.
Published: (2019-02-01)

Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD
by: Yanwei Wu, et al.
Published: (2021-08-01)

TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.
by: Yuka Koike, et al.
Published: (2023-03-01)

TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
by: Virginia Estades Ayuso, et al.
Published: (2023-08-01)

Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
by: Dickson Dennis W, et al.
Published: (2011-10-01)

TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans.
by: Alexandra Vaccaro, et al.
Published: (2012-07-01)

Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
by: Yuan Tian, et al.
Published: (2021-12-01)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
by: Matthew D. Cykowski, et al.
Published: (2018-04-01)

TDP-43 Pathology in Alzheimer’s Disease
by: Axel Meneses, et al.
Published: (2021-12-01)

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
by: Saebom Lee, et al.
Published: (2022-12-01)

The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
by: Ya-Fei Xu, et al.
Published: (2013-01-01)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
by: Manami Deshimaru, et al.
Published: (2021-04-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy
by: Bilal Khalil, et al.
Published: (2022-12-01)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
by: Marina Buciuc, et al.
Published: (2022-01-01)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
by: Hibiki Kawamata, et al.
Published: (2017-05-01)

Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration
by: Laura M. Taylor, et al.
Published: (2018-02-01)

Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments
by: Zhang Yong-Jie, et al.
Published: (2010-08-01)

LIPIDS ALTERATION IN TDP-43
by: Irene García Toledo, et al.
Published: (2023-10-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
by: Juan Carlos Rengifo-Gonzalez, et al.
Published: (2021-09-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
by: Liqun Liu-Yesucevitz, et al.
Published: (2010-10-01)

Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Metals in ALS TDP-43 Pathology
by: Lassi Koski, et al.
Published: (2021-11-01)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
by: Terry R. Suk, et al.
Published: (2020-08-01)

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
by: Yohei Iguchi, et al.
Published: (2012-03-01)

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
by: Nicola J Rutherford, et al.
Published: (2008-09-01)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
by: Sarah Lépine, et al.
Published: (2022-12-01)

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP
by: Feneberg, E, et al.
Published: (2021)

Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation
by: Bryony McCord, et al.
Published: (2023-09-01)